← 홈

전체 프로그램

ADC 1048 · Antibody 5323 · CGT 2737 · 다음 갱신 D-14 · 마지막 7월 20일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,110개
ADCBiologicstaleGilead SciencesPhase 3

Capecitabine Oral Product (Capecitabine Oral Product)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleSouth Eastern European Research…Phase 2

Capecitabine and Bevacizumab (Capecitabine and Bevacizumab)

Breast Cancer; Metastasis · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleUniversity of Medicine and Dent…Phase 2

Capecitabine and Cetuximab (Capecitabine and Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Capecitabine, Cetuximab, Oxaliplatin (Capecitabine, Cetuximab, Oxaliplatin)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbramson Cancer Center at Penn …Phase 2

Capecitabine, Oxaliplatin and Cetuximab (Capecitabine, Oxaliplatin and Cetuximab)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleShandong Cancer Hospital and In…Phase 2

trastuzumab (Herceptin, Capecitabine,Trastuzumab, and Pertuzumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 30%임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 3

Caplacizumab (Caplacizumab)

Acquired Thrombotic Thrombocytopenic Purpura · Acquired Thrombotic Thrombocytopenic Pur

#AcquiredThromboticThrombocytopen#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGroupe Oncologie Radiotherapie …Phase 2

Carbo, 5FU, Cetuximab (Carbo, 5FU, Cetuximab)

Metastatic or Recurrent Head and Neck Squamous Cell Cancer · Metastatic or Recurrent Head and Neck Sq

#MetastaticorRecurrentHeadandNeck#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

atezolizumab (Tecentriq, Carbo/cyclo + atezolizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleIntergroupe Francophone de Canc…Phase 2

durvalumab (Imfinzi, Carboplatin + Paclitaxel + Durvalumab)

Small Cell Lung Cancer Extensive Stage · Small Cell Lung Cancer Extensive Stage

#SmallCellLungCancerExtensiveStag#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleCentre Francois BaclessePhase 2

atezolizumab (Tecentriq, Carboplatin + Pemetrexed + Atezolizumab)

NSCLC Stage IIIB; NSCLC Stage IV · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
효능 ORR 64.6%임상시험 1상태 ACTIVE
AntibodystaleCentre Francois BaclessePhase 2

atezolizumab (Tecentriq, Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab)

NSCLC Stage IIIB; NSCLC Stage IV · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
효능 ORR 42.9%임상시험 1상태 ACTIVE
AntibodystaleVerastem, Inc.Phase 2

pembrolizumab (Keytruda, Carboplatin + Pemetrexed + Pembrolizumab)

Pancreatic Ductal Adenocarcinoma; Non Small Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

#PancreaticDuctalAdenocarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and nab-paclitaxel plus atezolizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and paclitaxel plus atezolizumab and bevacizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePreclinical

atezolizumab (Tecentriq, Carboplatin/Cisplatin -Etoposide - Atezolizumab)

Small Cell Lung Cancer; Large Cell Neuroendocrine (NE) Tumors · Small Cell Lung Cancer

#SmallCellLungCancer#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleXiangya Hospital of Central Sou…Phase 1

Cardunilizumab (Cardunilizumab)

Sarcoma, Soft Tissue · Sarcoma, Soft Tissue

#SarcomaSoftTissue#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, KRd, Carfilzomib, lenalidomide, dexamethasone, Carfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleCaribou Biosciences, Inc.Preclinical

Caribou-sponsored investigational therapy (Caribou-sponsored investigational therapy)

Lymphoma, Non-Hodgkin; Relapsed Non-Hodgkin Lymphoma · FRα

#FR#CGT#Preclinical#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE

111 / 206 페이지

← 이전다음 →